Nanjing Jin Sirui Biotechnology Co., Ltd. (Jin Site Technology (Nanjing) Co., Ltd.) was founded in 2002, is a global scale and international leader in biomedical R & D outsourcing service company. Headquartered in New Jersey Piscataway, and in China, France and Japan Division. World-class corporate clients mainly from the large pharmaceutical companies, biotechnology companies and more than 70 countries worldwide well-known research institutions.

present, Jin Sirui in Nanjing High-tech Development Zone, Jiangning registered capital of up to $ 100 million. The company employees 700 people, more than 10 manufacturing sectors. Employees in more than 120 master's, bachelor degree or above accounted for 70%of the total number of employees. Each department has graduated from famous universities in Europe and America experts, each expert has a well-known pharmaceutical companies in Europe or biotechnology services company for years of service, management experience, and in their respective areas to achieve fruitful results.

Jin Sirui committed early in the life sciences and drug discovery researchers to provide high-quality bio-technology outsourcing services, has a biological research reagent, drug screening, target drug optimization, the four antibody drug development great service platform. The one-stop service platform for biological research reagents for gene synthesis provides molecular biology services and related business objects, services, peptide synthesis, protein expression and purification services, antibodies and cell lines established services and other services. The company has developed into a world-class level of biomedical R & D outsourcing service company and a leading global supplier of gene synthesis.

Jin Sirui always "provide the best quality to customers, serving the interests of customers" for the idea. Based on this concept, our management system through the ISO9001 certification, provided the products meet cGMP levels, and more recently by AAALAC accreditation, and strive to provide the best service. At the same time, for different customers with different business models, including project models, directed full-time system model, the strategic alliance model. We understand the pharmaceutical industry is highly competitive, so give full consideration to the needs of customers, while ensuring every customer information is absolutely safe. It is because of our good development prospects and the correct business model, it has attracted well-known risk financial investment company KPCB and Balloch health care venture capital investment group!